OTCMKTS:GNWSF - GeneNews Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding GeneNews Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.05 +0.01 (+25.00 %) (As of 02/19/2020 04:00 PM ET) Add Compare Today's Range$0.05Now: $0.05▼$0.0550-Day Range$0.02MA: $0.03▼$0.0552-Week Range$0.02Now: $0.05▼$0.16Volume150,000 shsAverage Volume15,535 shsMarket Capitalization$14.75 millionP/E RatioN/ADividend YieldN/ABeta5.05 ProfileAdvanced ChartEarningsHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email GeneNews Limited focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology, the Sentinel Principle, identifies novel biomarkers from whole blood. The company's lead product is ColonSentry, a blood test to determine an individual's current risk for having colorectal cancer. GeneNews Limited was founded in 1998 and is headquartered in Richmond Hill, Canada. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Diagnostic substances Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:GNWSF Previous Symbol CUSIPN/A CIKN/A Webhttp://www.genenews.com/ Phone905-209-2030Debt Debt-to-Equity RatioN/A Current Ratio0.19 Quick Ratio0.14Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$190,000.00 Price / Sales77.64 Cash FlowN/A Price / Cash FlowN/A Book Value($0.03) per share Price / Book-1.67Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-3,940,000.00 Net Margins-2,760.90% Return on EquityN/A Return on Assets-116.47%Miscellaneous Employees16 Outstanding Shares295,014,000Market Cap$14.75 million Next Earnings Date2/20/2020 (Estimated) OptionableNot Optionable Receive GNWSF News and Ratings via Email Sign-up to receive the latest news and ratings for GNWSF and its competitors with MarketBeat's FREE daily newsletter. OTC:GNWSF Rates by TradingView GeneNews (OTCMKTS:GNWSF) Frequently Asked Questions What is GeneNews' stock symbol? GeneNews trades on the OTCMKTS under the ticker symbol "GNWSF." When is GeneNews' next earnings date? GeneNews is scheduled to release their next quarterly earnings announcement on Thursday, February 20th 2020. View Earnings Estimates for GeneNews. Has GeneNews been receiving favorable news coverage? News articles about GNWSF stock have been trending somewhat positive recently, according to InfoTrie. The research firm scores the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. GeneNews earned a news sentiment score of 0.7 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for GeneNews. Who are some of GeneNews' key competitors? Some companies that are related to GeneNews include Riot Blockchain (RIOT), Celldex Therapeutics (CLDX), ImmuCell (ICCC), Trinity Biotech (TRIB), Arca Biopharma (ABIO), Achieve Life Sciences (ACHV), Akers Biosciences (AKER), BG Medicine (BGMD), Fluoropharma Medical (FPMI) and Response Genetics (RGDXQ). What other stocks do shareholders of GeneNews own? Based on aggregate information from My MarketBeat watchlists, some companies that other GeneNews investors own include Pure Energy Minerals (PE), OrganiGram (OGI), BBX Capital (BBXTB), Obsidian Energy (OBE), Canopy Growth (CGC), CytRx (CYTR), Athabasca Oil (ATH), Oritani Financial (ORIT), Newmark Group (NMRK) and Menlo Therapeutics (MNLO). Who are GeneNews' key executives? GeneNews' management team includes the folowing people: Mr. James R. Howard-Tripp, Exec. Chairman & CEOMs. Joanna M. Halsey Esq., Gen. Counsel, Chief Compliance Officer & HR Director of IDLProf. Choong-Chin Liew Ph.D., Co-FounderMr. Warren Whitehead, Chief Accountant (Age 67)Mr. David Suria, Sr. Scientist How do I buy shares of GeneNews? Shares of GNWSF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is GeneNews' stock price today? One share of GNWSF stock can currently be purchased for approximately $0.05. How big of a company is GeneNews? GeneNews has a market capitalization of $14.75 million and generates $190,000.00 in revenue each year. GeneNews employs 16 workers across the globe.View Additional Information About GeneNews. What is GeneNews' official website? The official website for GeneNews is http://www.genenews.com/. How can I contact GeneNews? GeneNews' mailing address is 70 East Beaver Creek Road Unit 30, Richmond Hill A6, L4B 3B2. The company can be reached via phone at 905-209-2030 or via email at [email protected] MarketBeat Community Rating for GeneNews (OTCMKTS GNWSF)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 69 (Vote Outperform)Underperform Votes: 62 (Vote Underperform)Total Votes: 131MarketBeat's community ratings are surveys of what our community members think about GeneNews and other stocks. Vote "Outperform" if you believe GNWSF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GNWSF will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/19/2020 by MarketBeat.com StaffFeatured Article: How to build a Fibonacci channel
